B-Type Natriuretic Peptide in Pregnant Women With Heart Disease
B-Type Natriuretic Peptide in Pregnant Women With Heart Disease
复制标题
DOI:
10.1016/j.jacc.2010.02.076
复制
发表时间:
2010-10-05
影响因子:
24
通讯作者:
Silversides, Candice K.
中科院分区:
文献类型:
--
作者:
Tanous, David;Siu, Samuel C.;Silversides, Candice K.
Objectives The objectives of this study were to examine: 1) B-type natriuretic peptide (BNP) response to pregnancy in women with heart disease; and 2) the relationship between BNP levels and adverse maternal cardiac events during pregnancy.Background Pregnancy imposes a hemodynamic stress on the heart. BNP might be a useful biomarker to assess the ability of the heart to adapt to the hemodynamic load of pregnancy.Methods This was a prospective study of women with structural heart disease seen at our center. Serial clinical data and plasma BNP measurements were obtained during the first trimester, third trimester, and after delivery (>6 weeks).Results Seventy-eight pregnant women were studied; 66 women with heart disease (age 31 +/- 5 years), and 12 healthy women (age 33 +/- 5 years). During pregnancy, the median peak BNP level was higher in women with heart disease compared with control subjects (median 79, interquartile range 51 to 152 pg/ml vs. median 35, interquartile range 21 to 43 pg/ml, p < 0.001). In women with heart disease, those with subaortic ventricular dysfunction had higher BNP levels (p = 0.03). A BNP >100 pg/ml was measured in all women with events during pregnancy (n = 8). Sixteen women had increased BNP levels during pregnancy but did not have clinical events. None of the women with BNP